Insertions in the Reverse Transcriptase Increase both Drug Resistance and Viral Fitness in a Human Immunodeficiency Virus Type 1 Isolate Harboring the Multi-Nucleoside Reverse Transcriptase Inhibitor Resistance 69 Insertion Complex Mutation
Open Access
- 15 October 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (20) , 10546-10552
- https://doi.org/10.1128/jvi.76.20.10546-10552.2002
Abstract
Recent studies have shown that the accumulation of multiple mutations associated with nucleoside reverse transcriptase inhibitor (NRTI) resistance may be grouped as multi-NRTI resistance (MNR) complexes. In this study, we have examined the viral fitness of recombinant viruses carrying the reverse transcriptase (RT) of a human immunodeficiency virus type 1 (HIV-1) primary isolate harboring mutations comprising the MNR 69 insertion complex. Different RT mutants were prepared in the sequence context of either the wild-type RT sequence of the HIV-1BH10 isolate or the sequence found in a clinical HIV-1 isolate with the MNR 69 insertion mutation. As expected, in the presence of zidovudine, recombinant viruses harboring the MNR RT from the patient were more fit than wild-type viruses. However, in the absence of drug, the virus with the RT from the original clinical isolate (SS) was more fit than (i) the wild-type virus with an engineered serine insertion between residues 69 and 70 (T69SSS) and (ii) the recombinant virus with the MNR RT where the insertion was removed (2S0S). These results suggest that RT insertions, in the right sequence context (i.e., additional mutations contained in the MNR 69 insertion complex), enhance NRTI resistance and may improve viral fitness. Thus, comparing complex mutation patterns with viral fitness may help to elucidate the role of uncharacterized drug resistance mutations in antiretroviral treatment failure.Keywords
This publication has 43 references indexed in Scilit:
- Adefovir and Tenofovir Susceptibilities of HIV-1 After 24 to 48 Weeks of Adefovir Dipivoxil Therapy: Genotypic and Phenotypic Analyses of Study GS-96-408JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Selection by AZT and Rapid Replacement in the Absence of Drugs of HIV Type 1 Resistant to Multiple Nucleoside AnalogsAIDS Research and Human Retroviruses, 2001
- Genotypic and Phenotypic Resistance Patterns of Human Immunodeficiency Virus Type 1 Variants with Insertions or Deletions in the Reverse Transcriptase (RT): Multicenter Study of Patients Treated with RT InhibitorsAntimicrobial Agents and Chemotherapy, 2001
- Multi-drug Resistant HIV-1Journal of Infection, 2000
- Prevalence of Multiple Dideoxynucleoside Analogue Resistance (MddNR) in a Multicenter Cohort of HIV-1–Infected Italian Patients With Virologic FailureJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- A Novel Genotype Encoding a Single Amino Acid Insertion and Five Other Substitutions Between Residues 64 and 74 of the HIV-1 Reverse Transcriptase Confers High-Level Cross-Resistance to Nucleoside Reverse Transcriptase InhibitorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- HIV-1 evolution under pressure of protease inhibitors: Climbing the stairs of viral fitnessJournal of Biomedical Science, 1999
- Analysis of amino insertion mutations in the fingers subdomain of HIV-1 reverse transcriptase 1 1Edited by J. KarnJournal of Molecular Biology, 1999
- A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.Journal of Clinical Investigation, 1998
- Genetic Variation of HIV Type 1 in Four World Health Organization-Sponsored Vaccine Evaluation Sites: Generation of Functional Envelope (Glycoprotein 160) Clones Representative of Sequence Subtypes A, B, C, and EAIDS Research and Human Retroviruses, 1994